What is the life expectancy for stage 3 and stage 4 cirrhosis?

Reviewed by Yoshinori Abe, MD

Internal Medicine

Life expectancy for cirrhosis differs substantially between stage 3 and stage 4. Stage 3 cirrhosis (decompensated, without severe complications) has a median survival of roughly 6 years, while stage 4 cirrhosis—marked by advanced complications like variceal bleeding, ascites, or hepatic encephalopathy—drops median survival to about 1–2 years without a liver transplant. The gap reflects the extent of liver damage, complication severity, and how well the liver can still function.

Because symptoms like fatigue, swelling, jaundice, or confusion can signal progression, understanding where you stand matters. A free, instant, online symptom check can help you identify red flags, clarify potential causes, and guide your next steps—whether that's scheduling a specialist visit, adjusting lifestyle factors, or seeking urgent care. Taking 3 minutes now could shape the years ahead.

Reviewed for medical accuracy: 07/14/2026

Hi, I'm Shiba. I know these statistics can feel overwhelming, but your situation is unique to you. Would you like to check your specific symptoms or learn about the factors that can actually help improve your outlook? Ask me anything below.

Select an option or type a question below.

How can I improve my prognosis?What are the signs of stage 4?Check my symptoms now

Explanation

Understanding Cirrhosis Stages

Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. The stages of cirrhosis are typically classified as:

Stage 1 (Compensated Cirrhosis): The liver is damaged but still functions well.
Stage 2 (Compensated Cirrhosis): The liver is more damaged, but the patient may not have symptoms.
Stage 3 (Decompensated Cirrhosis): The liver is severely damaged, and complications such as ascites (fluid buildup), variceal bleeding, or hepatic encephalopathy may occur.
Stage 4 (End-Stage Liver Disease): The liver is critically damaged, and the patient may experience severe complications, leading to a high risk of mortality.

Life Expectancy for Stage 3 Cirrhosis

Patients with stage 3 cirrhosis generally have a life expectancy ranging from 1 to 5 years, depending on various factors such as the underlying cause of cirrhosis, the presence of complications, and the effectiveness of management strategies. Some patients may live longer with appropriate medical care and lifestyle changes.

Life Expectancy for Stage 4 Cirrhosis

In contrast, stage 4 cirrhosis, also known as end-stage liver disease, is associated with a significantly reduced life expectancy. The prognosis for patients with stage 4 cirrhosis is often poor, with many patients having a life expectancy of less than 1 year without a liver transplant. The presence of severe complications, such as liver failure or hepatocellular carcinoma (liver cancer), can further decrease life expectancy.

Factors Influencing Prognosis

Several factors can influence the prognosis and life expectancy of patients with cirrhosis, including:

Underlying Cause: The cause of cirrhosis (e.g., alcohol-related, viral hepatitis, non-alcoholic fatty liver disease) can impact outcomes.
Complications: The presence and severity of complications can significantly affect life expectancy.
Management and Treatment: Access to medical care, adherence to treatment, and lifestyle modifications (such as diet and alcohol cessation) can improve outcomes. If you're experiencing symptoms related to liver health, you can check your symptoms with a free AI-powered tool to better understand when to seek medical attention.

(References)

Kumar R, Kumar S, Prakash SS. Compensated liver cirrhosis: Natural course and disease-modifying strategies. World J Methodol. 2023 Sep 20;13(4):179-193. doi: 10.5662/wjm.v13.i4.179. PMID: 37771878; PMCID: PMC10523240.
Axley P, Mudumbi S, Sarker S, Kuo YF, Singal AK. Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS One. 2018 May 10;13(5):e0197117. doi: 10.1371/journal.pone.0197117. Erratum in: PLoS One. 2018 Aug 2;13(8):e0199402. doi: 10.1371/journal.pone.0199402. PMID: 29746540; PMCID: PMC5944985.
Mallik M, Singhai A, Khadanga S, Ingle V. The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis. Cureus. 2022 Jan 14;14(1):e21226. doi: 10.7759/cureus.21226. PMID: 35174029; PMCID: PMC8841014.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.